The AAMC joined nearly 120 health services research stakeholders in Feb. 22 letters to leaders from the House and Senate appropriations committees that recommend an investment of $500 million for the Agency for Healthcare Research and Quality (AHRQ) in fiscal year (FY) 2022.
In the letters, the stakeholders, as members of the Friends of AHRQ, noted the agency’s role in supporting primary care and health services research to improve health care quality through increased patient safety and access to care. The letter also described AHRQ’s role in addressing the inequities demonstrated within and beyond health care as a result of the ongoing COVID-19 pandemic.
“AHRQ provides the resources that policymakers, health system leaders, medical providers, and patients need to determine the effectiveness of health systems delivery,” the stakeholders wrote. “In order to deliver better outcomes, we need to be able to differentiate which healthcare interventions work, for whom they work, and how to implement them.”
The letter also highlighted how AHRQ complements other research agencies in improving health care delivery and promoting the nation’s well-being. “AHRQ is the federal vehicle for studying and improving the United States healthcare system, and it needs the resources to meet its mission and this moment. Through this appropriation level, AHRQ will be better able to fund the ‘last mile’ of research from cure to care,” the letter concluded.